Back to Library
Specialist Review

Screening & Diagnostics

Umbilical Artery & MCA Doppler

Clinical review of this update pending
3 min read
Editorial update: 2026-10-20
Placental resistanceUmbilical artery PI
RedistributionMCA PI / CPR
Anaemia assessmentMCA peak velocity
Clinical contextDecision

In brief — the direct answer

Fetal Doppler ultrasound assesses blood-flow waveforms in selected vessels. Umbilical artery Doppler helps assess placental resistance; MCA measurements can assess redistribution or, using peak systolic velocity, the risk of anaemia. These are different measurements with different meanings. Interpretation uses gestation, a specified reference, growth, fluid, heart-rate monitoring and maternal health. Doppler does not directly measure the baby’s oxygen level or guarantee wellbeing.

What is Umbilical Artery & MCA Doppler?

Umbilical artery PI and end-diastolic flow help identify increased placental resistance. MCA PI and the cerebroplacental ratio (MCA PI divided by umbilical artery PI) may indicate redistribution, sometimes called brain-sparing; they do not prove brain injury or exclude it. MCA peak systolic velocity, usually reported as multiples of the median, is used for a different question: possible fetal anaemia. Ductus venosus assessment has a role in selected specialist pathways, particularly very early severe FGR.

Who is at risk?

Doppler may be indicated with suspected FGR, placental disease, red-cell antibodies or particular twin complications. The vessel and frequency depend on the question. Reduced movements need prompt maternity assessment; a Doppler appointment alone is not a substitute for triage and the appropriate fetal assessment.

How we diagnose it

A technically valid waveform, correct vessel and sampling site, gestational age and appropriate reference are essential. A centile, ratio or MoM must be interpreted with its named reference and clinical indication. Guidelines differ in routine use of MCA/CPR and ductus venosus in FGR; explain which protocol applies. A borderline or unexpected result may require repeat expert measurement.

Fetal Doppler: Where We Sample. Umbilical artery, middle cerebral artery and ductus venosus.Enlarge schematic
Fetal Doppler: Where We Sample

Umbilical artery, middle cerebral artery and ductus venosus.

Simplified educational schematic; not to scale or for diagnosis.

What does management involve?

High resistance may prompt closer surveillance. Absent or reversed umbilical artery end-diastolic flow needs urgent specialist assessment and often intensified monitoring or admission. Delivery timing considers gestation, persistence, fetal heart-rate findings, growth and maternal condition. It is not determined by a universal rule of delivery within hours. Steroids, neuroprotection and neonatal consultation may be indicated if early birth is anticipated.

What are the outcomes?

Doppler-informed surveillance can improve decisions in high-risk pregnancy, but it cannot eliminate stillbirth or all neonatal harm. A normal result is reassuring only within the assessment and time at which it was obtained. Keep follow-up appointments and report reduced movements or new symptoms even after a reassuring test.

When to see a subspecialist

Request prompt review of abnormal Doppler, suspected growth restriction or possible fetal anaemia. Reversed flow or concerning fetal/maternal symptoms warrants urgent maternity assessment. Ask which vessel is abnormal, the gestation-specific interpretation, the next test and the changes that would lead to admission or delivery.

Questions to ask your doctor

No. It describes a change in circulation. It needs assessment in context and is not a diagnosis of brain injury.
No. PI assesses waveform resistance; peak systolic velocity is used in anaemia assessment. They are not interchangeable.
It is a serious finding requiring urgent specialist management. The delivery decision uses gestation and the full maternal and fetal assessment.
There is no established home treatment that repairs placental resistance. Follow the monitoring plan and discuss prescribed treatment for the underlying condition.

References & Clinical Guidelines

  1. Practice Guidelines: diagnosis and management of SGA and fetal growth restriction — ISUOG (2020)
  2. Consult Series #52: Diagnosis and management of fetal growth restriction — SMFM (2020)
  3. Clinical Guideline #8: The fetus at risk for anaemia — diagnosis and management (reaffirmed 2025) — SMFM (2015)
Share this resource